• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Quantitative relationship of preexisting homotypic antibodies to excretion of poliovirus types 1, 2, and 3 following the feeding of trivalent attenuated poliovirus vaccine.

作者信息

Glezen W P, McCollough R H, Lamb G A, Chin T D

出版信息

Am J Epidemiol. 1969 Aug;90(2):146-56. doi: 10.1093/oxfordjournals.aje.a121058.

DOI:10.1093/oxfordjournals.aje.a121058
PMID:4308600
Abstract
摘要

相似文献

1
Quantitative relationship of preexisting homotypic antibodies to excretion of poliovirus types 1, 2, and 3 following the feeding of trivalent attenuated poliovirus vaccine.
Am J Epidemiol. 1969 Aug;90(2):146-56. doi: 10.1093/oxfordjournals.aje.a121058.
2
[Excretion rates after Sabin oral vaccination against poliomyelitis in Tyrol].[蒂罗尔地区口服萨宾脊髓灰质炎疫苗后的排泄率]
Arch Hyg Bakteriol. 1968 Dec;152(5):410-4.
3
[Development of immunity to the poliomyelitis virus in infants with various methods of administering a live poliomyelitis vaccine].[采用不同方法给婴儿接种脊髓灰质炎活疫苗后对脊髓灰质炎病毒免疫力的发展情况]
Vopr Virusol. 1979 May-Jun(3):252-9.
4
Properties of a new type 3 attenuated poliovirus. VI. Alimentary tract resistance in children fed previously with type 3 Sabin vaccine to reinfection with homologous and heterologous type 3 attenuated poliovirus.一种新型3型减毒脊髓灰质炎病毒的特性。VI. 先前接种过3型萨宾疫苗的儿童对同源和异源3型减毒脊髓灰质炎病毒再感染的消化道抵抗力。
Arch Gesamte Virusforsch. 1967;20(1):87-98.
5
Monovalent type 1 oral poliovirus vaccine in newborns.新生儿用单价1型口服脊髓灰质炎疫苗
N Engl J Med. 2008 Oct 16;359(16):1655-65. doi: 10.1056/NEJMoa0800390.
6
Effect of prior immunity on the shedding of virulent revertant virus in feces after oral immunization with live attenuated poliovirus vaccines.既往免疫对口服减毒活脊髓灰质炎病毒疫苗后粪便中强毒回复株病毒排出的影响。
J Infect Dis. 1991 Jul;164(1):191-4. doi: 10.1093/infdis/164.1.191.
7
Quantitative relationship of preexisting homotypic antibodies to the excretion of attenuated poliovirus type 1.既往同型抗体与1型减毒脊髓灰质炎病毒排泄的定量关系。
Am J Epidemiol. 1966 Mar;83(2):224-37. doi: 10.1093/oxfordjournals.aje.a120578.
8
Mucosal immunity after vaccination with monovalent and trivalent oral poliovirus vaccine in India.印度接种单价和三价口服脊髓灰质炎疫苗后的黏膜免疫。
J Infect Dis. 2009 Sep 1;200(5):794-801. doi: 10.1086/605330.
9
Antigenic and biochemical characterization of poliovirus type 2 isolated from two cases of paralytic disease.
Intervirology. 1987;27(4):196-204. doi: 10.1159/000149985.
10
Detection of polioviruses in human cerebrospinal fluid.人类脑脊液中脊髓灰质炎病毒的检测
Arch Gesamte Virusforsch. 1968;25(3):359-62. doi: 10.1007/BF01556564.

引用本文的文献

1
Indian Academy of Pediatrics (IAP) Advisory Committee on Vaccines and Immunization Practices (ACVIP): Recommended Immunization Schedule (2020-21) and Update on Immunization for Children Aged 0 Through 18 Years.印度儿科学会 (IAP) 疫苗和免疫实践咨询委员会 (ACVIP)：推荐免疫计划 (2020-21 年) 及对 0 至 18 岁儿童免疫接种的更新。
Indian Pediatr. 2021 Jan 15;58(1):44-53. doi: 10.1007/s13312-021-2096-7. Epub 2021 Nov 29.
2
Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria.现场萨宾疫苗的返祖现象：尼日利亚类似萨宾株脊髓灰质炎病毒分离株的综合分析
J Virol. 2015 Oct 14;90(1):317-31. doi: 10.1128/JVI.01532-15. Print 2016 Jan 1.
3
Impact of inactivated poliovirus vaccine on mucosal immunity: implications for the polio eradication endgame.
灭活脊髓灰质炎疫苗对黏膜免疫的影响：对脊髓灰质炎根除收官阶段的启示
Expert Rev Vaccines. 2015;14(8):1113-23. doi: 10.1586/14760584.2015.1052800. Epub 2015 Jul 9.
4
The potential impact of expanding target age groups for polio immunization campaigns.扩大脊髓灰质炎免疫接种运动目标年龄组的潜在影响。
BMC Infect Dis. 2014 Jan 29;14:45. doi: 10.1186/1471-2334-14-45.
5
Review and assessment of poliovirus immunity and transmission: synthesis of knowledge gaps and identification of research needs.脊髓灰质炎病毒免疫和传播的回顾与评估：知识空白的综合分析与研究需求的确定。
Risk Anal. 2013 Apr;33(4):606-46. doi: 10.1111/risa.12031. Epub 2013 Mar 28.
6
Expert review on poliovirus immunity and transmission.脊髓灰质炎病毒免疫与传播专家综述。
Risk Anal. 2013 Apr;33(4):544-605. doi: 10.1111/j.1539-6924.2012.01864.x. Epub 2012 Jul 15.
7
Trends in the risk of U.S. polio outbreaks and poliovirus vaccine availability for response.美国脊髓灰质炎疫情风险和应对所需的脊灰疫苗供应的变化趋势。
Public Health Rep. 2012 Jan-Feb;127(1):23-37. doi: 10.1177/003335491212700104.
8
Antigenic sequences of poliovirus recognized by T cells: serotype-specific epitopes on VP1 and VP3 and cross-reactive epitopes on VP4 defined by using CD4+ T-cell clones.T细胞识别的脊髓灰质炎病毒抗原序列：利用CD4 + T细胞克隆确定的VP1和VP3上的血清型特异性表位以及VP4上的交叉反应表位
J Virol. 1992 Dec;66(12):7012-20. doi: 10.1128/JVI.66.12.7012-7020.1992.
9
The response to oral poliovaccine in persons aged 16-18 years.16至18岁人群对口服脊髓灰质炎疫苗的反应。
J Hyg (Lond). 1976 Apr;76(2):235-47. doi: 10.1017/s0022172400055133.